Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1406Neoplasms 1131Prostatic Neoplasms 746Lung Neoplasms 622Colorectal Neoplasms 598Carcinoma, Non-Small-Cell Lung 571Carcinoma, Hepatocellular 416Pancreatic Neoplasms 401Leukemia, Myeloid, Acute 398Stomach Neoplasms 356Multiple Myeloma 327Brain Neoplasms 313Ovarian Neoplasms 309Head and Neck Neoplasms 292Neoplasm Metastasis 277Precursor Cell Lymphoblastic Leukemia-Lymphoma 261Rectal Neoplasms 255Uterine Cervical Neoplasms 248Recurrence 248Melanoma 243Esophageal Neoplasms 237Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 230Lymphoma 214Sarcoma 209Urinary Bladder Neoplasms 194Colonic Neoplasms 192Glioma 191Triple Negative Breast Neoplasms 190Hematologic Neoplasms 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × OTHER × Safety Issues × Clear all
NCT06509490 2024-07-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Recruiting
9 enrolled

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon âš¡